Biotech Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids October 11, 2024
Biotech GenScript Biotech Advances Sustainable Development with MSCI ESG Rating Upgrade to A October 11, 2024
Biotech AMERICAS GOLD AND SILVER CORPORATION ANNOUNCES UPSIZE OF PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT OF SUBSCRIPTION RECEIPTS TO C$45 MILLION October 10, 2024
Biotech Astellas to Present VEOZA™ (fezolinetant) Data at IMS World Congress on Menopause October 10, 2024
Biotech Oncoinvent Announces First Patient Dosed in its Phase 2 Clinical Trial of Radspherin® in Ovarian Cancer Patients October 10, 2024
Biotech Antag Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Lead Molecule, AT-7687 October 9, 2024
Biotech BioCorteX Unveils Critical Bacteria Interactions in ADC Cancer Treatment, Enabled by Google Cloud October 9, 2024
Biotech CTC ━ Centro De Tecnologia Canavieira Engages SC Solutions To Provide AI Technology for Sugarcane October 8, 2024
Biotech Adcendo Announces US FDA Clearance of IND Application for Phase I/II First-in-Human ADCElerate-01 Trial of ADCE-D01 (uPARAP Receptor Targeting ADC) Trial in Patients With Metastatic and/or Unresectable Soft Tissue Sarcoma (STS) October 8, 2024